August 28, 2009
When Congress members return in two weeks, they will be discussing a health care reform bill that attempts to provide care for the uninsured and to address our skyrocketing health care costs. Simultaneously, however, the House and Senate are considering proposals that would prevent lower-cost pharmaceuticals from coming to market by regulating generic versions of biologics known as follow-on biologics or "biosimilars." Biologics, protein-based pharmaceuticals produced within living cells, include all vaccines, most new cancer agents, and critical arthritis and psoriasis drugs.
August 30, 2009
Del. Cardin apologizes for marriage-proposal stunt I would like to apologize for my actions surrounding my marriage proposal, any confusion that my absence on a previously scheduled vacation may have contributed, and the embarrassing attention that it has engendered. What should have been a joyous time of my life became one that was instead marked by errors in judgment. I take full responsibility for initiating this incident. I should have been sensitive enough to realize that these are extraordinarily difficult times in Baltimore, both financially and from a public safety perspective.
December 1, 2004
The nation's sole licensed producer of anthrax vaccine will open a plant in Frederick, a potential $100 million facility that adds to Maryland's growing strength in vaccine research and production. Officials of Emergent BioLogics Inc. -- a unit of newly created parent Emergent BioSolutions of Gaithersburg -- said yesterday that the plant will employ 100 workers in its first phase and eventually as many as 300 to produce BioThrax, the only anthrax vaccine approved for use in the United States.
February 9, 1994
Layoffs at U.S. firms hit highMajor corporations announced 108,000 layoffs in January, the highest monthly level in the four years since the figures have been tracked, a consulting firm said yesterday.Challenger, Gray & Christmas Inc., based in Chicago, said the level of announced layoffs topped even the worst of the 1990 recession.Communications companies GTE Corp., NYNEX Corp. and Pacific Telesis Group cut a total of almost 44,000 workers.Spectrum to sue Sculley todaySpectrum Information Technologies Inc., the wireless data company stunned Monday by the resignation of John Sculley as chairman and chief executive officer, said yesterday that it planned to file a federal lawsuit against Mr. Sculley, claiming damages of more than $300 million.
October 22, 1994
GM shares fall to 52-week lowGeneral Motors Corp.'s shares fell for a second day yesterday, to a 52-week low, as four investment houses cut their earnings estimates yesterday following Thursday's disappointing third-quarter results.Analysts panned the stock, saying some of the problems that led to a $328 million loss at GM's North American car and truck business -- high costs for overtime, freight and new-model launches -- are likely to continue.GM stock has lost 12 percent of its value since Wednesday.
December 21, 1993
MedImmune decides not to buyMedImmune Inc. said yesterday that it had ended negotiations to buy Melville Biologics because the proposed purchase was not in the best interests of its shareholders.Gaithersburg-based MedImmune had previously signed a letter of intent to acquire the Melville Biologics division of the New York Blood Center for $40 million in common stock, about $4 million in cash and some royalty payments.MedImmune develops, makes and markets therapeutics and vaccines for the treatment of certain infectious diseases and cancers.